Barth, R.F., Yang, W., Huo, T., Riley, K., Binns, P., Grecula, J., Gupta, N., Rousseau, J., and Elleaume, H. Comparison of intracerebral delivery of carboplatin and photon irradiation with an optimized regimen for boron neutron capture therapy of F98 rat glioma. Applied Radiation & Isotopes 69:1813-1816, 2011.
Kawabata S., Yang, W., Barth, R.F., Wu, G., Huo, T., Binns, P.J., Riley, K.J., Ongayi, O., Gottumukkala, V., and Vicente, M.G.H.: Convection enhanced delivery of carboranylporphyrins for neutron capture therapy of brain tumors. J. Neuro-Oncology 103: 175-185, 2011.
Yang, W., Huo, T., Barth, R.F., Gupta, N., Weldon, M., Grecula, J.C., Ross, B.D., Hoff, B.A., Rousseau, J., and Elleaume, H.: Convection enhanced delivery of carboplatin in combination with radiotherapy for the treatment of brain tumors. J. Neuro-Oncology 101: 379-390, 2011.
Rousseau, J., Barth, R.F., Fernandez, M., Adam, J.-F., Balosso, J., Esteve, F., and Elleaume, H. Efficacy of intracerebral delivery of cisplatin in combination with photon irradiation for treatment of brain tumors. J. Neuro-oncology 98: 287-295. 2010.
Barth, R.F. and Kaur, B. Rat brain tumor models in experimental neuro-oncolgy: the C6, 9L, T9, RG2, F98, BTC4L, RT-2 and CNS-1 gliomas. J. Neuro-Oncology 94: 299-312, 2009.
Rolf Barth, MD is a Professor in the Experimental Pathology Branch. Dr. Barth earned his undergraduate degree at Cornell University and his MD from the College of Physicians & Surgeons, Columbia University in New York City. He completed a surgical internship in the Department of Surgery at Columbia University Medical Center. He was a USPHS Postdoctoral Fellow in the Department of Tumor Biology at the Karolinska Institute in Stockholm, Sweden. He completed a residency in Anatomic Pathology at the National Cancer Institute in Bethesda, MD, and has been on the Autopsy Service for more than 30 years. Dr. Barth’s research has focused on innovative radiotherapeutic strategies for the treatment of brain tumors using rat tumor models. The first approach focuses on boron neutron capture therapy (BNCT), specifically, the evaluation of new boron-containing tumor-targeting agents. The second approach focuses on the combination of intracerebral administration of platinum-containing drugs in combination with photon irradiation.